IHH Healthcare’s YTD 2024 earnings drop 13% YoY

Excluding exceptional items, earnings grew by 35%.

IHH Healthcare registered a net profit of $573m (RM$1.9b) in year-to-date (YTD) 2024, dropping 13% year-on-year (YoY).

The decrease was due to a high base last year, which recorded one-off gains of $263m (RM873.0m) from the sale of International Medical University (IMU). Excluding exceptional items, net profit grew by 35%.

Revenue and EBITDA for the period posted double-digit growth of 13% and 12%, respectively, reaching $5.3b (RM17.7b) and $1.2b (RM4.0b). The growth was driven by sustained increases in patient volumes and revenue intensity across all markets.

For Q3 2024, IHH Healthcare achieved a 73% occupancy rate, with 232,071 patient admissions across 12,220 operational beds.

In the next five years, the group intends to add approximately 4,000 new beds under its “Align-Challenge-Empower” (ACE) framework.

Follow the link for more news on

IHH Healthcare

Financial Statements

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia